Brickell Biotech Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Brickell Biotech Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10592
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Brickell Biotech Inc (Brickell Biotech) is a pharmaceutical company that develops differentiated therapeutics for the treatment of skin diseases. The company offers pipeline product candidates such as BBI-4000, BBI-5000, BBI-2000, BBI-3000 and BBI -6000. Its product candidate BBI-4000 is an anticholinergic used for the treatment of primary axillary hyperhidrosis; BBI-5000, a selective oral immunomodulator for moderate to severe atopic dermatitis. Brickell Biotech’s BBI-2000, is an anti-inflammatory peptide in pre-clinical stage for contact dermatitis, and BBI-3000, a potent topical and oral retinoid in pre-clinical stage for the treatment of acne. The company serves cosmetic and aesthetics companies, pharmaceutical and healthcare companies. Brickell Biotech is headquartered in Boulder, Colorado, the US.

Brickell Biotech Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Brickell Biotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Brickell Biotech Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Brickell Biotech Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Brickell Biotech Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Brickell Biotech Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Brickell Biotech Inc, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Brickell Biotech Acquires Rights to RORy Inhibitors from Orca Pharma 10
Venture Financing 11
Brickell Biotech Raises USD10 Million in Series C Financing 11
Brickell Biotech Raises USD2.2 Million in Venture Financing 12
Brickell Biotech Raises US$7 Million In Series B Financing 13
Licensing Agreements 14
Brickell Biotech Enters into Licensing Agreement with Kaken Pharma 14
Brickell Biotech Enters into Licensing Agreement with Merz North America for BBI-3000 15
Brickell Biotech Enters into Licensing Agreement with Bodor Labs 16
Argyle Therapeutics Enters Into Licensing Agreement With Brickell Biotech For Rosacea Drug 17
Brickell Biotech Inc – Key Competitors 18
Brickell Biotech Inc – Key Employees 19
Brickell Biotech Inc – Locations And Subsidiaries 20
Head Office 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Brickell Biotech Inc, Pharmaceuticals & Healthcare, Key Facts 2
Brickell Biotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Brickell Biotech Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Brickell Biotech Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Brickell Biotech Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Brickell Biotech Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Brickell Biotech Acquires Rights to RORy Inhibitors from Orca Pharma 10
Brickell Biotech Raises USD10 Million in Series C Financing 11
Brickell Biotech Raises USD2.2 Million in Venture Financing 12
Brickell Biotech Raises US$7 Million In Series B Financing 13
Brickell Biotech Enters into Licensing Agreement with Kaken Pharma 14
Brickell Biotech Enters into Licensing Agreement with Merz North America for BBI-3000 15
Brickell Biotech Enters into Licensing Agreement with Bodor Labs 16
Argyle Therapeutics Enters Into Licensing Agreement With Brickell Biotech For Rosacea Drug 17
Brickell Biotech Inc, Key Competitors 18
Brickell Biotech Inc, Key Employees 19

List of Figures
Brickell Biotech Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Brickell Biotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Brickell Biotech Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Brickell Biotech Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Brickell Biotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Brickell Biotech Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Brickell Biotech Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Brickell Biotech Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Brickell Biotech Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • United Therapeutics Corp (UTHR):医療機器:M&Aディール及び事業提携情報
    Summary United Therapeutics Corp (UTC) develops and commercializes innovative pharmaceutical products for the treatment of cardiovascular disorders, particularly pulmonary arterial hypertension and infectious diseases. The company's products consist of prostacyclin analogues including Remodulin (tre …
  • Austevoll Seafood Asa:企業の戦略・SWOT・財務分析
    Austevoll Seafood Asa - Strategy, SWOT and Corporate Finance Report Summary Austevoll Seafood Asa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Eastman Chemical Company:企業のM&A・事業提携・投資動向
    Eastman Chemical Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Eastman Chemical Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Meyer Burger Technology AG (MBTN):企業の財務・戦略的SWOT分析
    Meyer Burger Technology AG (MBTN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Bonduelle Sca
    Bonduelle Sca - Strategy, SWOT and Corporate Finance Report Summary Bonduelle Sca - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Genel Energy Plc (GENL):企業の財務・戦略的SWOT分析
    Genel Energy Plc (GENL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Team Energy Corporation:企業の戦略的SWOT分析
    Team Energy Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • The Bank of Iwate Ltd:企業の戦略・SWOT・財務情報
    The Bank of Iwate Ltd - Strategy, SWOT and Corporate Finance Report Summary The Bank of Iwate Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Macmahon Holdings Ltd:企業の戦略・SWOT・財務情報
    Macmahon Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Macmahon Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Becton Dickinson and Co (BDX):企業の財務・戦略的SWOT分析
    Becton Dickinson and Co (BDX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Ngai Hing Hong Co Ltd (1047):企業の財務・戦略的SWOT分析
    Ngai Hing Hong Co Ltd (1047) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Anika Therapeutics Inc (ANIK):企業の製品パイプライン分析2018
    Summary Anika Therapeutics Inc (Anika) develops, manufactures, and markets therapeutic products for tissue protection, repair and regeneration. It offers solutions for orthobiologics, dermal, ophthalmic, surgical and veterinary applications. Its major products include viscosupplementation and regene …
  • Comerica Incorporated:企業の戦略・SWOT・財務情報
    Comerica Incorporated - Strategy, SWOT and Corporate Finance Report Summary Comerica Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • UnitedHealth Group Inc (UNH):製薬・医療:M&Aディール及び事業提携情報
    Summary UnitedHealth Group Inc (UnitedHealth Group) is a diversified health care company. It offers health care services and products through two distinct platforms, namely UnitedHealthcare and Optum. Its UnitedHealthcare platform provides health care coverage and benefit services; and Optum platfor …
  • Hwa Tai Industries Berhad:企業の戦略・SWOT・財務分析
    Hwa Tai Industries Berhad - Strategy, SWOT and Corporate Finance Report Summary Hwa Tai Industries Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Topaz Energy and Marine Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Topaz Energy and Marine Ltd (Topaz), a subsidiary of Renaissance Services SAOG, is an oil and gas company that offers offshore support vessels and marine solutions. The company's services include platform supply, anchor handling, emergency recovery and response and crew transfer. It operates …
  • IDACORP, Inc.:企業の戦略・SWOT・財務分析
    IDACORP, Inc. - Strategy, SWOT and Corporate Finance Report Summary IDACORP, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Parkway Properties Inc:企業のM&A・事業提携・投資動向
    Parkway Properties Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Parkway Properties Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • PACCAR Inc (PCAR):企業の財務・戦略的SWOT分析
    PACCAR Inc (PCAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Jardine Lloyd Thompson Group plc:企業の戦略・SWOT・財務分析
    Jardine Lloyd Thompson Group plc - Strategy, SWOT and Corporate Finance Report Summary Jardine Lloyd Thompson Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆